Sherwin-Williams (NYSE:SHW) Price Target Increased to $370.00 by Analysts at JPMorgan Chase & Co.

Sherwin-Williams (NYSE:SHWGet Free Report) had its target price raised by research analysts at JPMorgan Chase & Co. from $360.00 to $370.00 in a report issued on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the specialty chemicals company’s stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 1.91% from the stock’s current price.

SHW has been the topic of several other research reports. The Goldman Sachs Group raised their price objective on Sherwin-Williams from $344.00 to $390.00 and gave the stock a “buy” rating in a report on Wednesday, July 24th. KeyCorp restated a “sector weight” rating on shares of Sherwin-Williams in a research note on Monday, October 7th. Redburn Atlantic upgraded Sherwin-Williams to a “strong-buy” rating in a research note on Thursday, July 18th. UBS Group restated an “underperform” rating on shares of Sherwin-Williams in a research report on Friday, October 18th. Finally, StockNews.com raised shares of Sherwin-Williams from a “hold” rating to a “buy” rating in a report on Tuesday. One research analyst has rated the stock with a sell rating, six have given a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $390.71.

Get Our Latest Stock Analysis on SHW

Sherwin-Williams Stock Up 0.5 %

NYSE:SHW traded up $1.68 during mid-day trading on Wednesday, hitting $363.06. The stock had a trading volume of 677,514 shares, compared to its average volume of 1,539,765. Sherwin-Williams has a twelve month low of $232.06 and a twelve month high of $392.57. The stock has a 50-day simple moving average of $371.59 and a two-hundred day simple moving average of $334.45. The company has a current ratio of 0.81, a quick ratio of 0.50 and a debt-to-equity ratio of 2.17. The company has a market capitalization of $91.59 billion, a PE ratio of 37.13, a PEG ratio of 3.04 and a beta of 1.17.

Sherwin-Williams (NYSE:SHWGet Free Report) last posted its earnings results on Tuesday, October 22nd. The specialty chemicals company reported $3.37 EPS for the quarter, missing the consensus estimate of $3.56 by ($0.19). The business had revenue of $6.16 billion during the quarter, compared to analysts’ expectations of $6.20 billion. Sherwin-Williams had a net margin of 10.92% and a return on equity of 75.58%. The business’s quarterly revenue was up .7% compared to the same quarter last year. During the same period last year, the company earned $3.20 EPS. On average, equities research analysts anticipate that Sherwin-Williams will post 11.49 EPS for the current year.

Insider Transactions at Sherwin-Williams

In other news, CFO Allen J. Mistysyn sold 14,520 shares of the business’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $366.83, for a total value of $5,326,371.60. Following the completion of the transaction, the chief financial officer now directly owns 63,520 shares of the company’s stock, valued at $23,301,041.60. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 0.60% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Tamar Securities LLC boosted its position in shares of Sherwin-Williams by 3.4% in the third quarter. Tamar Securities LLC now owns 48,753 shares of the specialty chemicals company’s stock worth $18,608,000 after acquiring an additional 1,604 shares during the last quarter. Valeo Financial Advisors LLC boosted its holdings in shares of Sherwin-Williams by 7.9% in the 2nd quarter. Valeo Financial Advisors LLC now owns 2,636 shares of the specialty chemicals company’s stock valued at $787,000 after purchasing an additional 193 shares during the last quarter. Transcend Capital Advisors LLC grew its stake in shares of Sherwin-Williams by 24.1% during the 2nd quarter. Transcend Capital Advisors LLC now owns 7,805 shares of the specialty chemicals company’s stock valued at $2,329,000 after buying an additional 1,514 shares during the period. Handelsbanken Fonder AB increased its holdings in shares of Sherwin-Williams by 4.3% during the 3rd quarter. Handelsbanken Fonder AB now owns 98,118 shares of the specialty chemicals company’s stock worth $37,449,000 after buying an additional 4,074 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S raised its position in shares of Sherwin-Williams by 17.3% in the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 20,592 shares of the specialty chemicals company’s stock worth $7,152,000 after buying an additional 3,031 shares during the period. 77.67% of the stock is currently owned by institutional investors and hedge funds.

Sherwin-Williams Company Profile

(Get Free Report)

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.

Read More

Analyst Recommendations for Sherwin-Williams (NYSE:SHW)

Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.